ConductScience.org, home

Paper37631985

BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1.

Jiang L and 8 others. Viruses, 2023. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1. Papers, record 37631985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37631985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1.
PubMed
Journal
Viruses
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2023-09-07
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiang LLefang
2Yu YYang
3Li ZZhuogang
4Gao YYarou
5Zhang HHaonan
6Zhang MMingxin
7Cao WWeihua
8Peng QQun
9Chen XXulinhttps://orcid.org/0000-0002-4479-1145

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Herpesvirus 1, HumanMajor topic
Herpes SimplexMajor topic
Infant, Newborn
Humans
HeLa Cells
Protein Kinase Inhibitors
Antiviral Agents
Cyclin-Dependent Kinases

Source PubMed

Download CSV of topics

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112135584Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.Drug Resist Updat2002https://conductscience.org/library/papers/12135584PubMed
214561402Cdk2 knockout mice are viable.Curr Biol2003https://conductscience.org/library/papers/14561402PubMed
39377190Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy.Oral Surg Oral Med Oral Pathol Oral Radiol Endod1997https://conductscience.org/library/papers/9377190PubMed
412589832Herpes simplex virus resistance to antiviral drugs.J Clin Virol2003https://conductscience.org/library/papers/12589832PubMed
525036183Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile α motif and HD domain-containing protein-1 (SAMHD1) activity.AIDS2014https://conductscience.org/library/papers/25036183PubMed
620465793An overview of Cdk1-controlled targets and processes.Cell Div2010https://conductscience.org/library/papers/20465793PubMed
726542306Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1.J Antimicrob Chemother2016https://conductscience.org/library/papers/26542306PubMed
814739611Apoptosis participates to liver damage in HSV-induced fulminant hepatitis.Apoptosis2003https://conductscience.org/library/papers/14739611PubMed
925003190CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.J Clin Invest2014https://conductscience.org/library/papers/25003190PubMed
109621021Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.J Virol1998https://conductscience.org/library/papers/9621021PubMed
1115494896Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.Clin Infect Dis2004https://conductscience.org/library/papers/15494896PubMed
1211729253Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes.J Am Soc Nephrol2001https://conductscience.org/library/papers/11729253PubMed
1323901090Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.J Infect Dis2013https://conductscience.org/library/papers/23901090PubMed
1431241436Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment.Med Chem2020https://conductscience.org/library/papers/31241436PubMed
1534747367Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19.JCI Insight2021https://conductscience.org/library/papers/34747367PubMed
1621778105Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.J Clin Virol2011https://conductscience.org/library/papers/21778105PubMed
17304261586-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.Cancer Chemother Pharmacol2019https://conductscience.org/library/papers/30426158PubMed
1833618979Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics.Trends Microbiol2021https://conductscience.org/library/papers/33618979PubMed
199971799Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.J Virol1999https://conductscience.org/library/papers/9971799PubMed
2023596085Recent developments in anti-herpesvirus drugs.Br Med Bull2013https://conductscience.org/library/papers/23596085PubMed

See all 46 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42943421Proprietary Cationic Lipo-Oligopeptides Inhibit Herpes Simplex Virus-1 Infection.Microorganisms2026https://conductscience.org/library/papers/42943421PubMed
42823736CDK7, CDK9, or CDK11 inhibition reduces neutrophil-driven inflammation and tissue damage in experimental autoimmune models.Cell Commun Signal2026https://conductscience.org/library/papers/42823736PubMed
42075693CMGC Kinases in Viral Infection and Human Disease.Pathogens2026https://conductscience.org/library/papers/42075693PubMed
41827841Phosphoproteome Remodeling upon CDK1 Inhibition Restricts HSV-1 IE Gene Transcription and Replication.Cells2026https://conductscience.org/library/papers/41827841PubMed
41594640Marine Derived Natural Products: Emerging Therapeutics Against Herpes Simplex Virus Infection.Biomolecules2026https://conductscience.org/library/papers/41594640PubMed
41575212A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention.mBio2026https://conductscience.org/library/papers/41575212PubMed
41327028Integrating of Machine Learning to Characterize Tumor-Infiltrating Immune Cell-Related Signature for Enhancing Prognosis for Glioma Patients.Biol Proced Online2025https://conductscience.org/library/papers/41327028PubMed
39931979Cyclin Dependent Kinases in Antiviral Drug Discovery.Curr Med Chem2025https://conductscience.org/library/papers/39931979PubMed
39466139The opportunities and challenges of epigenetic approaches to manage herpes simplex infections.Expert Rev Anti Infect Ther2024https://conductscience.org/library/papers/39466139PubMed
38616855Herpes simplex keratitis: A brief clinical overview.World J Virol2024https://conductscience.org/library/papers/38616855PubMed
38259968Anti-herpes simplex virus activities and mechanisms of marine derived compounds.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/38259968PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37631985

GET https://conductscience.org/api/papers/v1/37631985/references?page=2